Evaluation of paclitaxel and SDZ PSC [valspodar] in recurrent platinum resistant and refractory ovarian cancer
Latest Information Update: 23 Dec 2005
At a glance
- Drugs Paclitaxel (Primary) ; Valspodar (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 23 Dec 2005 New trial record.